Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ferrer

Showing results (81-90 of 293) with videos related to

Pageof 30
Sort By:
Actas Espanolas De Psiquiatria|September 20, 2016
Study of prevalence of Personality Disorders in inmate men sample with Substance Use Disorders using of PDQ-4+ Self-ReportNatalia Calvo, Viviana Nasillo, Marc Ferrer, et al.
Actas Espanolas De Psiquiatria|August 7, 2018
Dimensional Personality Assessment among a Chronic Fatigue Syndrome (CFS) sample with Personality Inventory for DSM-5 (PID-5)Natalia Calvo, Natalia Pueyo, Fernando Gutiérrez, et al.
Current Protocols in Chemical Biology|January 7, 2014
Multiplexing high-content flow (HCF) and quantitative high-throughput screening (qHTS) to identify compounds capable of decreasing cell viability, activating caspase 3/7, expressing annexin V, and changing mitochondrial membrane integrityLesley A Mathews, Jonathan M Keller, Crystal McKnight, et al.
Journal of Biomolecular Screening|July 24, 2012
Identification of a selective small-molecule inhibitor series targeting the eyes absent 2 (Eya2) phosphatase activityAaron B Krueger, Seameen J Dehdashti, Noel Southall, et al.
Journal of Addictive Diseases|December 22, 2016
Severity factors associated with borderline personality disorder among misusers in an outpatient sample in SpainCarmen Barral, Constanza Daigre, Diana Bachiller, et al.
CNS Drugs|June 13, 2008
Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate : a chart review of Spanish adults with attention-deficit hyperactivity disorderJosep Antoni Ramos-Quiroga, Rosa Bosch, Xavier Castells, et al.
Journal of Biomolecular Screening|April 27, 2016
Ranking Differential Drug Activities from Dose-Response Synthetic Lethality ScreensRajarshi Guha, Lesley A Mathews Griner, Jonathan M Keller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2016
Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung CancerDuane H Hamilton, Lesley Mathews Griner, Jonathan M Keller, et al.
Frontiers in Bioengineering and Biotechnology|March 11, 2020
Two-Dimensional Cellular and Three-Dimensional Bio-Printed Skin Models to Screen Topical-Use Compounds for Irritation PotentialZhengxi Wei, Xue Liu, Masato Ooka, et al.
Journal of the American Heart Association|December 25, 2017
Prognostic Value of New-Generation Troponins in ST-Segment-Elevation Myocardial Infarction in the Modern Era: The RUTI-STEMI StudyGermán Cediel, Ferran Rueda, Cosme García, et al.
Pageof 30

Showing results (81-90 of 293) with videos related to

Sort By:
Pageof 30
Actas Espanolas De Psiquiatria|September 20, 2016
Study of prevalence of Personality Disorders in inmate men sample with Substance Use Disorders using of PDQ-4+ Self-ReportNatalia Calvo, Viviana Nasillo, Marc Ferrer, et al.
Actas Espanolas De Psiquiatria|August 7, 2018
Dimensional Personality Assessment among a Chronic Fatigue Syndrome (CFS) sample with Personality Inventory for DSM-5 (PID-5)Natalia Calvo, Natalia Pueyo, Fernando Gutiérrez, et al.
Current Protocols in Chemical Biology|January 7, 2014
Multiplexing high-content flow (HCF) and quantitative high-throughput screening (qHTS) to identify compounds capable of decreasing cell viability, activating caspase 3/7, expressing annexin V, and changing mitochondrial membrane integrityLesley A Mathews, Jonathan M Keller, Crystal McKnight, et al.
Journal of Biomolecular Screening|July 24, 2012
Identification of a selective small-molecule inhibitor series targeting the eyes absent 2 (Eya2) phosphatase activityAaron B Krueger, Seameen J Dehdashti, Noel Southall, et al.
Journal of Addictive Diseases|December 22, 2016
Severity factors associated with borderline personality disorder among misusers in an outpatient sample in SpainCarmen Barral, Constanza Daigre, Diana Bachiller, et al.
CNS Drugs|June 13, 2008
Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate : a chart review of Spanish adults with attention-deficit hyperactivity disorderJosep Antoni Ramos-Quiroga, Rosa Bosch, Xavier Castells, et al.
Journal of Biomolecular Screening|April 27, 2016
Ranking Differential Drug Activities from Dose-Response Synthetic Lethality ScreensRajarshi Guha, Lesley A Mathews Griner, Jonathan M Keller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2016
Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung CancerDuane H Hamilton, Lesley Mathews Griner, Jonathan M Keller, et al.
Frontiers in Bioengineering and Biotechnology|March 11, 2020
Two-Dimensional Cellular and Three-Dimensional Bio-Printed Skin Models to Screen Topical-Use Compounds for Irritation PotentialZhengxi Wei, Xue Liu, Masato Ooka, et al.
Journal of the American Heart Association|December 25, 2017
Prognostic Value of New-Generation Troponins in ST-Segment-Elevation Myocardial Infarction in the Modern Era: The RUTI-STEMI StudyGermán Cediel, Ferran Rueda, Cosme García, et al.
Pageof 30